GFA
BMY icon

Godfrey Financial Associates’s Bristol-Myers Squibb BMY Stock Holding History

Godfrey Financial Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.9K Sell
988
-254
-20% -$14.6K 0.04% 232
2026
Q1 		$75.3K Hold
1,242
– – 0.06% 183
2025
Q4 		$67K Buy
+1,242
New +$59.7K 0.06% 185

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Godfrey Financial Associates's BMY Position: Q2 2026 in Review

Godfrey Financial Associates reduced its Bristol-Myers Squibb (BMY) stake by 20% in Q2 2026, selling an estimated $14.6K and leaving 988 shares worth $56.9K. The position accounts for 0.04% of the portfolio, ranked #232.

Godfrey Financial Associates first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $75.3K in Q1 2026. 2,505 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Godfrey Financial Associates held 988 shares of Bristol-Myers Squibb worth $56.9K as of Q2 2026.
  • Godfrey Financial Associates sold 254 Bristol-Myers Squibb shares in Q2 2026, an estimated $14.6K.
  • Bristol-Myers Squibb made up 0.04% of Godfrey Financial Associates's portfolio in Q2 2026, its #232 holding.
  • Godfrey Financial Associates first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Godfrey Financial Associates's Bristol-Myers Squibb position peaked at $75.3K in Q1 2026.
  • 2,505 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Godfrey Financial Associates's 13F filing for Q2 2026, filed 11 Aug 2026.